Holen Sie sich die Stockscreener-App
48.29
0.33%
-0.16
Schlusskurs vom Vortag:
$48.45
Offen:
$48.58
24-Stunden-Volumen:
1.26M
Relative Volume:
1.07
Marktkapitalisierung:
$9.95B
Einnahmen:
$2.04B
Nettoeinkommen (Verlust:
$373.39M
KGV:
28.47
EPS:
1.6961
Netto-Cashflow:
$495.96M
1W Leistung:
+6.86%
1M Leistung:
+5.99%
6M Leistung:
+0.69%
1J Leistung:
+3.73%
1-Tages-Spanne:
$47.86
$48.75
1-Wochen-Bereich:
$45.02
$49.01
52-Wochen-Spanne:
$37.74
$51.88
Qiagen Nv Stock (QGEN) Company Profile
Firmenname
Qiagen Nv
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie QGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
48.29 | 9.98B | 2.04B | 373.39M | 495.96M | 1.6961 |
|
TMO
Thermo Fisher Scientific Inc
|
618.86 | 227.87B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
238.37 | 165.99B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
713.35 | 56.89B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
148.52 | 41.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
242.41 | 41.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-06-24 | Eingeleitet | Barclays | Overweight |
| 2025-04-04 | Herabstufung | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | Hochstufung | Jefferies | Hold → Buy |
| 2024-10-17 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-06-27 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-12-07 | Hochstufung | Goldman | Neutral → Buy |
| 2023-09-12 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-05-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-01-18 | Hochstufung | DZ Bank | Hold → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-10-14 | Eingeleitet | Redburn | Buy |
| 2021-07-14 | Herabstufung | Kepler | Buy → Hold |
| 2021-06-03 | Eingeleitet | Goldman | Neutral |
| 2020-10-06 | Fortgesetzt | BofA Securities | Buy |
| 2020-09-28 | Hochstufung | Kepler | Hold → Buy |
| 2020-08-24 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-08-17 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-08-14 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | Herabstufung | Berenberg | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-12-26 | Fortgesetzt | BofA/Merrill | Underperform |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-11-14 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-11-14 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2019-11-14 | Hochstufung | Kepler | Reduce → Hold |
| 2019-10-17 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | Herabstufung | Kepler | Hold → Reduce |
| 2019-10-08 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-10-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
Alle ansehen
Qiagen Nv Aktie (QGEN) Neueste Nachrichten
Qiagen (NYSE:QGEN) Stock Rating Lowered by Wall Street Zen - MarketBeat
Qiagen N.V.: How a Quiet Workflow Powerhouse Is Shaping the Future of Molecular Diagnostics - AD HOC NEWS
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView — Track All Markets
Release according to Article 40, Section 1 of the WpHG - TradingView — Track All Markets
Qiagen N : announces adjustment of conversion price under its US$ 500,000,000 Convertible Bonds due 2027 - MarketScreener
Will Qiagen N.V. stock recover faster than peersStock Surge & Low Risk Profit Maximizing Plans - ulpravda.ru
Why Qiagen N.V. Common Shares stock trades below fair valueJuly 2025 Spike Watch & Reliable Breakout Forecasts - ulpravda.ru
Is Qiagen N.V. stock in correction or buying zoneWeekly Trading Summary & Daily Volume Surge Signals - ulpravda.ru
Will Qiagen N.V. (QIA) stock outperform value peersWeekly Profit Recap & Detailed Earnings Play Strategies - ulpravda.ru
Qiagen NV To Carry Out 19-for-20 Reverse Stock Split On January 8th, 2026 - 富途牛牛
How Qiagen N.V. stock valuations compare to rivalsMarket Volume Summary & Risk Controlled Daily Trade Plans - ulpravda.ru
Sectors Review: How buybacks impact Qiagen N.V. stock valueWeekly Profit Recap & High Conviction Investment Ideas - ulpravda.ru
PTA-NVR: QIAGEN N.V.: Total Voting Rights Announcement according to Article 41 of the WpHG - TradingView — Track All Markets
Total Voting Rights Announcement according to Article 41 of the WpHG - TradingView — Track All Markets
Qiagen NV To Go Ex-Dividend On January 8th, 2026 With 2.29 USD Dividend Per Share And 19-for-20 Reverse Stock Split - 富途牛牛
Fivespan Said to Build Stake in Life Sciences Group Qiagen - MSN
Gateway Investment Advisers LLC Takes Position in Qiagen N.V. $QGEN - MarketBeat
Citi Maintains Qiagen NV(QGEN.US) With Hold Rating - 富途牛牛
Generali Asset Management SPA SGR Increases Holdings in Qiagen N.V. $QGEN - MarketBeat
Qiagen and Gencurix partner for oncology tests - MSN
Weekly Trades: Why Qiagen NV Common Shares stock trades below fair valueJuly 2025 Momentum & Low Risk High Win Rate Stock Picks - moha.gov.vn
Qiagen N.V. (NYSE:QGEN) is a favorite amongst institutional investors who own 82% - Yahoo Finance
Qiagen N.V.: Quiet Accumulation Or Fading Momentum? A Deep Look At The Stock Behind Molecular Diagno - AD HOC NEWS
Allspring Global Investments Holdings LLC Raises Holdings in Qiagen N.V. $QGEN - MarketBeat
Reproductive Genetics Market Size to Reach USD 16.67 Billion in 2032 Amid Increasing Demand for Genetic Testing - GlobeNewswire Inc.
Burney Co. Purchases Shares of 38,699 Qiagen N.V. $QGEN - MarketBeat
Qiagen sees synthetic share repurchase completed in January - MSN
Qiagen (NYSE:QGEN) Shares Set to Reverse Split on Thursday, January 8th - MarketBeat
Qiagen N.V. (NYSE:QGEN) Given Average Rating of "Hold" by Analysts - MarketBeat
Qiagen N.V. $QGEN Shares Sold by Voya Investment Management LLC - MarketBeat
Qiagen (NYSE:QGEN) Rating Increased to Buy at Wall Street Zen - MarketBeat
Growth Value: Is ONE Gas Inc OG9 stock attractive for dividend growthWeekly Stock Report & Weekly High Momentum Picks - moha.gov.vn
What Wall Street predicts for Qiagen N.V. stock priceQuarterly Profit Summary & Daily Growth Stock Investment Tips - Улправда
How Qiagen N.V. stock performs in rising dollar environment2025 Year in Review & Stepwise Entry and Exit Trade Signals - bolumsonucanavari.com
Qiagen’s US$500 Million Synthetic Buyback Might Change The Case For Investing In Qiagen (QGEN) - Sahm
What sentiment indicators say about Qiagen N.V. stockTake Profit & Safe Capital Growth Tips - Улправда
Whale Trades: How buybacks impact Qiagen N.V. stock valueJuly 2025 Short Interest & Safe Entry Momentum Tips - Улправда
Can Qiagen N.V. stock beat market expectations this quarter2025 EndofYear Setup & Expert Approved Trade Ideas - DonanımHaber
Can Qiagen N.V. Common Shares stock sustain revenue momentum2025 Support & Resistance & Real-Time Chart Breakout Alerts - DonanımHaber
Why Qiagen N.V. stock is recommended by analysts2025 Trade Ideas & Long-Term Growth Stock Strategies - Bölüm Sonu Canavarı
Aug Sectors: How interest rate cuts could boost Qiagen N.V. stockM&A Rumor & Smart Allocation Stock Reports - Улправда
Trend Review: Can Qiagen NV stock maintain growth trajectoryJuly 2025 Intraday Action & Stepwise Trade Execution Plans - moha.gov.vn
[6-K] QIAGEN N.V. Current Report (Foreign Issuer) | QGEN SEC FilingForm 6-K - Stock Titan
Published on: 2025-12-19 07:09:16 - Улправда
Published on: 2025-12-19 04:35:20 - Улправда
Qiagen Details on Completion of $500 Million Synthetic Share Repurchase - 富途牛牛
QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Mi - PharmiWeb.com
Qiagen price target raised to $55 from $53 at Barclays - MSN
QIAGEN to return $500 million to shareholders through share repurchase By Investing.com - Investing.com Nigeria
QIAGEN Announces Details For Completion Of Synthetic Share Repurchase Of Up To Approximately $500 Million >QGEN - 富途牛牛
QIAGEN to return $500 million to shareholders through share repurchase - Investing.com
Finanzdaten der Qiagen Nv-Aktie (QGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
0.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):